Literature DB >> 22190720

Molecular signatures associated with Mx1-mediated resistance to highly pathogenic influenza virus infection: mechanisms of survival.

Cristian Cilloniz1, Mary J Pantin-Jackwood, Chester Ni, Victoria S Carter, Marcus J Korth, David E Swayne, Terrence M Tumpey, Michael G Katze.   

Abstract

Understanding the role of host factors during lethal influenza virus infection is critical to deciphering the events that determine the fate of the host. One such factor is encoded by the Mx1 gene, which confers resistance to influenza virus infection. Here, we compared pathology and global gene expression profiles in lung tissue from BALB/c (Mx1(-)) and BALB · A2G-Mx1 mice (Mx1(+/+)) infected with the fully reconstructed 1918 pandemic influenza virus. Mx1(+/+) mice showed less tissue damage than Mx(-) animals, and pathology and mortality were further reduced by treating the mice with interferon prior to infection. Using global transcriptional profiling, we identified distinct molecular signatures associated with partial protection, complete protection, and the contribution of interferon to the host response. In the absence of interferon treatment, partial protection was characterized by the generation of an acute response with the upregulation of genes associated with apoptosis, reactive oxygen species, and cell migration. Complete protection was characterized by the downregulation of cytokine and chemokine genes previously associated with influenza virus pathogenesis. The contribution of interferon treatment to total protection in virus-infected Mx1(+/+) mice was characterized by the altered regulation of cell cycle genes. These genes were upregulated in Mx1(+/+) mice treated with interferon but downregulated in the absence of interferon treatment. Our results suggest that Mx1(+/+) mice generate a protective antiviral response by controlling the expression of key modulator molecules associated with influenza virus lethality.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22190720      PMCID: PMC3302269          DOI: 10.1128/JVI.06156-11

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  37 in total

1.  Influenza virus-susceptible mice carry Mx genes with a large deletion or a nonsense mutation.

Authors:  P Staeheli; R Grob; E Meier; J G Sutcliffe; O Haller
Journal:  Mol Cell Biol       Date:  1988-10       Impact factor: 4.272

2.  Mx protein: constitutive expression in 3T3 cells transformed with cloned Mx cDNA confers selective resistance to influenza virus.

Authors:  P Staeheli; O Haller; W Boll; J Lindenmann; C Weissmann
Journal:  Cell       Date:  1986-01-17       Impact factor: 41.582

3.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

Authors:  P Chomczynski; N Sacchi
Journal:  Anal Biochem       Date:  1987-04       Impact factor: 3.365

4.  Clinical features and rapid viral diagnosis of human disease associated with avian influenza A H5N1 virus.

Authors:  K Y Yuen; P K Chan; M Peiris; D N Tsang; T L Que; K F Shortridge; P T Cheung; W K To; E T Ho; R Sung; A F Cheng
Journal:  Lancet       Date:  1998-02-14       Impact factor: 79.321

5.  Influenza virus regulates protein synthesis during infection by repressing autophosphorylation and activity of the cellular 68,000-Mr protein kinase.

Authors:  M G Katze; J Tomita; T Black; R M Krug; B Safer; A Hovanessian
Journal:  J Virol       Date:  1988-10       Impact factor: 5.103

6.  Differential regulation of antiviral and proinflammatory cytokines and suppression of Fas-mediated apoptosis by NS1 of H9N2 avian influenza virus in chicken macrophages.

Authors:  Zheng Xing; Carol J Cardona; Sean Adams; Zengqi Yang; Jinling Li; Daniel Perez; Peter R Woolcock
Journal:  J Gen Virol       Date:  2009-03-04       Impact factor: 3.891

7.  Intranasal vaccination with 1918 influenza virus-like particles protects mice and ferrets from lethal 1918 and H5N1 influenza virus challenge.

Authors:  Lucy A Perrone; Attiya Ahmad; Vic Veguilla; Xiuhua Lu; Gale Smith; Jacqueline M Katz; Peter Pushko; Terrence M Tumpey
Journal:  J Virol       Date:  2009-03-25       Impact factor: 5.103

8.  Polyclonal and monoclonal antibodies to the interferon-inducible protein Mx of influenza virus-resistant mice.

Authors:  P Staeheli; P Dreiding; O Haller; J Lindenmann
Journal:  J Biol Chem       Date:  1985-02-10       Impact factor: 5.157

9.  A unique cap(m7GpppXm)-dependent influenza virion endonuclease cleaves capped RNAs to generate the primers that initiate viral RNA transcription.

Authors:  S J Plotch; M Bouloy; I Ulmanen; R M Krug
Journal:  Cell       Date:  1981-03       Impact factor: 41.582

Review 10.  Interferon-inducible antiviral effectors.

Authors:  Anthony J Sadler; Bryan R G Williams
Journal:  Nat Rev Immunol       Date:  2008-07       Impact factor: 53.106

View more
  19 in total

1.  Implication of inflammatory macrophages, nuclear receptors, and interferon regulatory factors in increased virulence of pandemic 2009 H1N1 influenza A virus after host adaptation.

Authors:  Laurence Josset; Jessica A Belser; Mary J Pantin-Jackwood; Jean H Chang; Stewart T Chang; Sarah E Belisle; Terrence M Tumpey; Michael G Katze
Journal:  J Virol       Date:  2012-04-24       Impact factor: 5.103

Review 2.  Innate immunity to influenza virus infection.

Authors:  Akiko Iwasaki; Padmini S Pillai
Journal:  Nat Rev Immunol       Date:  2014-05       Impact factor: 53.106

3.  Susceptibility of Xenopus laevis tadpoles to infection by the ranavirus Frog-Virus 3 correlates with a reduced and delayed innate immune response in comparison with adult frogs.

Authors:  Francisco De Jesús Andino; Guangchun Chen; Zhenghui Li; Leon Grayfer; Jacques Robert
Journal:  Virology       Date:  2012-07-21       Impact factor: 3.616

4.  Dietary abscisic acid ameliorates influenza-virus-associated disease and pulmonary immunopathology through a PPARγ-dependent mechanism.

Authors:  Raquel Hontecillas; Paul C Roberts; Adria Carbo; Cristina Vives; William T Horne; Sandra Genis; Binu Velayudhan; Josep Bassaganya-Riera
Journal:  J Nutr Biochem       Date:  2012-09-17       Impact factor: 6.048

Review 5.  H5N1 pathogenesis studies in mammalian models.

Authors:  Jessica A Belser; Terrence M Tumpey
Journal:  Virus Res       Date:  2013-02-28       Impact factor: 3.303

Review 6.  Host genetic determinants of influenza pathogenicity.

Authors:  Tsai-Yu Lin; Abraham L Brass
Journal:  Curr Opin Virol       Date:  2013-08-08       Impact factor: 7.090

7.  Protection from Severe Influenza Virus Infections in Mice Carrying the Mx1 Influenza Virus Resistance Gene Strongly Depends on Genetic Background.

Authors:  Dai-Lun Shin; Bastian Hatesuer; Silke Bergmann; Tatiana Nedelko; Klaus Schughart
Journal:  J Virol       Date:  2015-07-22       Impact factor: 5.103

Review 8.  Systems approaches to influenza-virus host interactions and the pathogenesis of highly virulent and pandemic viruses.

Authors:  Marcus J Korth; Nicolas Tchitchek; Arndt G Benecke; Michael G Katze
Journal:  Semin Immunol       Date:  2012-12-05       Impact factor: 11.130

9.  Microarray analysis of microRNA expression in peripheral blood mononuclear cells of critically ill patients with influenza A (H1N1).

Authors:  Hao Song; Qi Wang; Yang Guo; Shunai Liu; Rui Song; Xuesong Gao; Li Dai; Baoshun Li; Deli Zhang; Jun Cheng
Journal:  BMC Infect Dis       Date:  2013-06-03       Impact factor: 3.090

Review 10.  MicroRNA as Type I Interferon-Regulated Transcripts and Modulators of the Innate Immune Response.

Authors:  Samuel C Forster; Michelle D Tate; Paul J Hertzog
Journal:  Front Immunol       Date:  2015-07-08       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.